<SEC-DOCUMENT>0001367644-23-000163.txt : 20230830
<SEC-HEADER>0001367644-23-000163.hdr.sgml : 20230830
<ACCEPTANCE-DATETIME>20230830063040
ACCESSION NUMBER:		0001367644-23-000163
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230830
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230830
DATE AS OF CHANGE:		20230830

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		231223665

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ebs-20230830.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:b40da2a5-f794-46a0-9c0a-20a22eec9163,g:d0105c80-8e5c-463b-a0bd-c33d096c529a,d:1c904a1a50b5423ebb1e02482f9019bf--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ebs-20230830</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ebs-20230830.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-30</xbrli:startDate><xbrli:endDate>2023-08-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1c904a1a50b5423ebb1e02482f9019bf_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">August 30, 2023</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-4">EMERGENT BIOSOLUTIONS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-33137</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">14-1902018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">400 Professional Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-9">Suite 400</ix:nonNumeric>,</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Gaithersburg</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">20879</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">240</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">631-3200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:10pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.109%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, Par Value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">EBS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in&#160;Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01. Other Events</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2023, Emergent BioSolutions Inc. (the &#8220;Company&#8221;) issued a press release announcing that NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and at online retailers beginning in September 2023, as an over-the-counter emergency treatment of opioid overdose. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#8239; Financial Statements and Exhibits</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d)         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a08302023otc.htm">Press release issued by Emergent BioSolutions Inc. on August 30, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMERGENT BIOSOLUTIONS INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RICHARD S. LINDAHL</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:  Richard S. Lindahl<br/>Title:  Executive Vice President, Chief Financial<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Officer and Treasurer</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a08302023otc.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i69f1e781a5d44f2c85c5ae4fedf3dfb8_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Emergent BioSolutions&#8217; NARCAN&#174; Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.66pt">Emergent has officially shipped its over the counter, original prescription strength NARCAN&#174; Naloxone HCl Nasal Spray 4 mg to leading mass, drug&#47;pharmacy and grocery stores, as well as online retailers</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.66pt">NARCAN&#174; Nasal Spray will be the first, life-saving emergency medicine for opioid overdose available on shelves beginning this September with a Manufacturer&#8217;s Suggested Retail Price of $44.99</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.66pt">Emergent remains committed to ensuring broad access, awareness and strong supply for essential public interest groups leading naloxone distribution efforts across the country</font></div><div><font><br></font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GAITHERSBURG, Md., </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">August 30</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2023 -- Today, Emergent BioSolutions Inc. (NYSE&#58; EBS) announced </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NARCAN&#174; Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and online beginning in September. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Over-the-counter (OTC) access to NARCAN&#174; Nasal Spray </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">offers more people the ability to respond in an opioid emergency</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, helping to save lives and keep loved ones and communities safe. Expanding access and awareness is critical given </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the staggering toll of the epidemic mainly driven by synthetic opioids</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, like fentanyl.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Last year, approximately every seven minutes one life was lost due to an opioid overdose, and today it is the leading cause of accidental death in the U.S.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">,3</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The average response time for emergency services to arrive is approximately 10 minutes.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Having NARCAN</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Nasal Spray in a first-aid kit, or carrying it on the go in case of an opioid emergency, can make a difference and help reverse the effects of opioids while waiting for emergency personnel to arrive. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a medical professional and mom who experienced the unthinkable and lost both of her sons to accidental overdose, I know you can&#8217;t put a price on peace of mind and there is no act too great to protect family,&#8221; said Dr. Bonnie Milas, Penn Medicine physician and professor of Clinical Anesthesiology and Critical Care. &#8220;Picking up NARCAN&#174; Nasal Spray at the store is not a sign that your family has &#8220;a problem,&#8221; in fact it shows you are prepared </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">just in case</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. It&#8217;s like buying a fire extinguisher to have at home &#8211; having the power to save a life of someone you love, someone you know, or someone that may need another chance.&#8221;</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the same safe and effective 4 mg formulation, device design and original prescription strength, NARCAN&#174; Nasal Spray can reverse the effects of opioids, including fentanyl. Consumers can expect the life-saving treatment to be widely available at leading mass, drug, grocery and online retailers beginning in September. The manufacturer&#8217;s suggested retail price of NARCAN&#174; Nasal Spray is $44.99 per carton, which is equivalent to roughly $22.50 per dose. While Emergent works with partners to help maintain access and affordability, the price of the product is set by individual retailers.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A steadfast commitment to expanding access to naloxone has always been at the forefront of our work to help save lives and we&#8217;re proud to bring NARCAN&#174; Nasal Spray to many, many more places,&#8221; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">said Paul Williams, Senior Vice President, Products Business. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Expanding availability to online and in-store shelves, increasing awareness and education to reduce stigma, and calling on the public to be prepared, is additive to the current work Emergent does every single day to stem the tide of this public health threat. On the eve of International Overdose Awareness Day, we stand by our ongoing efforts with advocates, patients, customers and policy stakeholders to implement efforts that enhance naloxone distribution to all those </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in need.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a leader in the fight against the opioid crisis, Emergent has not raised the price of the product since its launch in 2016, and the company is focused on broadening distribution and maintaining affordability. To that end, Emergent has lowered its public interest price for NARCAN&#174; Nasal Spray to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$41.00 per two-dose carton, effective August 31, 2023, building on its long-standing efforts with public interest partners to ensure naloxone is readily available to at-risk communities. Through federal grants and state and local government programs, many community organizations, first responders, and harm reduction groups can purchase NARCAN&#174; Nasal Spray and distribute it at no cost to them. These programs help ensure lifesaving products are available in communities across the country, particularly those that may be unable to reach lifesaving medical care quickly in emergencies. While the public interest distribution channels are vast, many qualified groups can continue to use Emergent&#8217;s online portal, NARCANDirect&#8482;, as one pathway to purchase and ship bulk quantities of NARCAN&#174; Nasal Spray to anywhere in the country.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">According to a March 2023 report by the Reagan-Udall Foundation, almost 17 million doses of naloxone were distributed in the U.S. in 2021. More than 84 percent of those doses were distributed through channels such as local health departments, harm reduction organizations, first responders, schools, and other community organizations.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Emergent recognizes the importance of these channels for naloxone access and will continue to support ongoing distribution to high-risk and underserved communities in need. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the prescription approval of NARCAN&#174; Nasal Spray in 2015, Emergent has more than seven years of real-world safety data, and we continue to evaluate trends across society, new opioid threats and are committed to doing our part in fighting the opioid epidemic. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For more information, visit NARCAN.com.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About NARCAN&#174; Nasal Spray</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NARCAN&#174; Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN&#174; Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Emergent BioSolutions </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At Emergent, our mission is to protect and enhance life. For 25 years, we&#8217;ve been at work defending people from things we hope will never happen&#8212;so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our&#8239;website&#8239;and follow us on&#8239; </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Instagram</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Safe Harbor Statement</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the development and commercial availability of </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NARCAN&#174; Naloxone HCl Nasal Spray 4 mg over-the-counter</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are forward-looking statements. We generally identify forward-looking </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">statements by using words like &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause the company&#8217;s actual results to differ materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Emergent BioSolutions Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Media Contact&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Matt Hartwig </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director, Media Relations </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">240-760-0551</font><font style="color:#2c2c29;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">hartwigm&#64;ebsi.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard Lindahl </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EVP and Chief Financial Officer </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">240-631-3360 </font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">lindahlr&#64;ebsi.com</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Centers for Disease Control and Prevention. Understanding the epidemic. Available at&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.cdc.gov&#47;opioids&#47;basics&#47;epidemic.html</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Updated June 1, 2022. Accessed August 2, 2023.</font></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Centers for Disease Control and Prevention. Provisional Drug Overdose Death Counds. Available at&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.cdc.gov&#47;nchs&#47;nvss&#47;vsrr&#47;drug-overdose-data.htm</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Updated February 15, 2023. Accessed August 25, 2023.</font></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Schiller EY, Goyal A, Mechanic OJ. Opioid overdose. NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. Available at&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.ncbi.nlm.nih.gov&#47;books&#47;NBK470415&#47;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Updated April 29, 2023. Accessed August 2, 2023.</font></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Gonzalez RP, Cummings GR, Mulekar MS, et al. Improving rural emergency medical service response time with global positioning system navigation. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">J. Trauma</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. 2009 Nov&#59;67(5)&#58;899-902.</font></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reagan-Udall Foundation. Naloxone economic view&#58; Summary report. March 2023. Available at&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;reaganudall.org&#47;sites&#47;default&#47;files&#47;2023-03&#47;Naloxone%20Report%20FINAL%203.10.23.pdf</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Accessed August 2, 2023.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ebs-20230830.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b40da2a5-f794-46a0-9c0a-20a22eec9163,g:d0105c80-8e5c-463b-a0bd-c33d096c529a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ebs="http://emergentbiosolutions.com/20230830" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://emergentbiosolutions.com/20230830">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230830_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230830_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage">
        <link:definition>0000001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ebs-20230830_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b40da2a5-f794-46a0-9c0a-20a22eec9163,g:d0105c80-8e5c-463b-a0bd-c33d096c529a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_3a108657-90a6-4501-9919-7e780993fb79_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_51a3bee3-2246-44e8-b3a0-9dd3b9e116c4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_cbc11de4-36e8-416b-8340-12577cf56cd9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4771a11a-8bfb-4645-ba06-ab6964c72219_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6bfb1ad4-373a-42bb-bc4a-46fa6866df0d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1a1a9c84-0932-47ae-aa89-00a001b9c763_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5d0f5c88-4575-4482-bda9-1b8c8f34072a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_47b4deda-c04c-46ff-9a81-967592282073_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a2107ca6-761a-41da-bc4f-1899f0878ed4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a2c20e5f-ba45-4731-9bab-7faee2e1ca37_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8a4a5377-3909-4e07-af82-c357745a81ab_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_c0705aa3-b95b-481a-b674-5deee2fd663b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_68efbcc0-b6e8-4eda-86b1-93584ff0959a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ec779af6-cb58-4d36-8dce-f9844b9e4eac_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d186d365-3733-45f7-83b1-d4d04a8bc21e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fd0843d6-9458-4b78-8afe-6f675dd4fe14_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_52125a84-9ba9-4969-baa7-99535b691944_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0d58a9a4-05f6-4de0-b53b-615e35b1d3cc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_64fb36c4-d8e1-42a7-ae73-a7bf4b68ef4f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9474c6c5-38a4-46ed-a83d-ae190977ad14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1902920e-ebee-47b6-8d1e-7ce7faedeec2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_79a4d636-9b7e-42d1-85ba-126e1bcf2a29_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_3ced53aa-d685-41ee-b1da-dfa37d183281_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9ac8564f-c8de-448e-b901-350e2dc70ac3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ebs-20230830_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:b40da2a5-f794-46a0-9c0a-20a22eec9163,g:d0105c80-8e5c-463b-a0bd-c33d096c529a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="ebs-20230830.xsd#CoverPageCoverPage"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_38a46233-2a4c-4986-9853-783bb4d629b2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_DocumentType_38a46233-2a4c-4986-9853-783bb4d629b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5c1412e4-5b2e-42dc-ae1b-c0b912c1f999" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_DocumentPeriodEndDate_5c1412e4-5b2e-42dc-ae1b-c0b912c1f999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a75679d8-c251-4042-a315-e286e9ab4fa9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityRegistrantName_a75679d8-c251-4042-a315-e286e9ab4fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1e3d9e8d-12fe-40b1-9762-a6dbd3fb0166" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1e3d9e8d-12fe-40b1-9762-a6dbd3fb0166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3059d5f9-8766-4d4e-903c-53a2b9e00e00" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityFileNumber_3059d5f9-8766-4d4e-903c-53a2b9e00e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b19d53ce-f43a-4da8-bbef-e9731e5968b9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityTaxIdentificationNumber_b19d53ce-f43a-4da8-bbef-e9731e5968b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_999ff449-9955-4bca-8f04-844460d237f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityAddressAddressLine1_999ff449-9955-4bca-8f04-844460d237f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_ac96d1c1-2534-4b9e-841e-23f141e0008b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityAddressAddressLine2_ac96d1c1-2534-4b9e-841e-23f141e0008b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f53523ab-ca28-4c83-9d24-1924abccf320" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityAddressCityOrTown_f53523ab-ca28-4c83-9d24-1924abccf320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_929fd9c8-450f-4204-9765-85cf67f85a76" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityAddressStateOrProvince_929fd9c8-450f-4204-9765-85cf67f85a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a68e7b68-67a0-4208-b297-e0ba1efc7a11" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityAddressPostalZipCode_a68e7b68-67a0-4208-b297-e0ba1efc7a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_71a99acb-903a-462d-8aad-cf5d1bd06005" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_CityAreaCode_71a99acb-903a-462d-8aad-cf5d1bd06005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_80b672da-4482-4933-a362-2195e2ab15fe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_LocalPhoneNumber_80b672da-4482-4933-a362-2195e2ab15fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_91b2540f-cfa6-4f21-bd87-bf8c65c06a31" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_WrittenCommunications_91b2540f-cfa6-4f21-bd87-bf8c65c06a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_717a9472-f49a-4144-a3f9-a6c663309778" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_SolicitingMaterial_717a9472-f49a-4144-a3f9-a6c663309778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f71e0bad-4883-44c6-bd14-cb6b23685fa0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_PreCommencementTenderOffer_f71e0bad-4883-44c6-bd14-cb6b23685fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a880037a-0b9b-497c-8679-791124b49be2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a880037a-0b9b-497c-8679-791124b49be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_72238ae2-a11a-477e-bdd3-ccaa4c1560dc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityEmergingGrowthCompany_72238ae2-a11a-477e-bdd3-ccaa4c1560dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8b8db68c-174e-4b7f-a75b-3954a455b722" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_Security12bTitle_8b8db68c-174e-4b7f-a75b-3954a455b722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8929cec1-6771-46e5-ac2d-463f11eaa74c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_TradingSymbol_8929cec1-6771-46e5-ac2d-463f11eaa74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7c8fb6e1-de19-4ab0-a093-61a7a9592c34" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_SecurityExchangeName_7c8fb6e1-de19-4ab0-a093-61a7a9592c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4132c06d-8eaa-405c-9218-c9b918a5f920" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_EntityCentralIndexKey_4132c06d-8eaa-405c-9218-c9b918a5f920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_01ab6e5a-ccf0-43c3-818b-b68bcc4eb2ef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9336ea99-5f27-4c4a-8a13-b529536d92af" xlink:to="loc_dei_AmendmentFlag_01ab6e5a-ccf0-43c3-818b-b68bcc4eb2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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MUZY=0U:M7*G?@TMGS\B6;X;+U#H/J;>_7\R2JYCOS AMS<"N<N'D[QHGD&H
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M/Z.R++YFAHS,9M:O*+NFC\_P-0/41<4*Y?3&#KSEB906-ZR0_=V>_93#+V2
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MS9 Y36K(Q,?S91$S'&?Q-6-#^MF#>V,>E5G<L$+&OKA$PU4 $(N0V;@L'+.
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3-((HALK-I     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140198078773168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 30,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMERGENT BIOSOLUTIONS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1902018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Professional Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-3200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EBS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ebs-20230830_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ebs-20230830.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-08-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001367644</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-08-30</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-08-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-4">EMERGENT BIOSOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-33137</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">14-1902018</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">400 Professional Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-9">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Gaithersburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">20879</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">631-3200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, Par Value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">EBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( -,S'E>7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ TS,>5^5HBNPY 0
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M<F]P<R]A<' N>&UL4$L! A0#%     @ TS,>5X%RTB;N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ TS,>
M5YE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " #3,QY7F[%0_F@$   W$0  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ TS,>
M5Y^@&_"Q @  X@P   T              ( !JPP  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " #3,QY7EXJ[',     3 @  "P              @ &'#P
M7W)E;',O+G)E;'-02P$"% ,4    " #3,QY7Y6B*[#D!   R @  #P
M        @ %P$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ TS,>5R0>
MFZ*M    ^ $  !H              ( !UA$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ TS,>5V60>9(9 0  SP,  !,
M     ( !NQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&!10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ebs-20230830.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CoverPageCoverPage</Role>
      <ShortName>Cover Page Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ebs-20230830.htm">ebs-20230830.htm</File>
    <File>a08302023otc.htm</File>
    <File>ebs-20230830.xsd</File>
    <File>ebs-20230830_lab.xml</File>
    <File>ebs-20230830_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ebs-20230830.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ebs-20230830.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ebs-20230830_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ebs-20230830_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ebs-20230830.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ebs",
   "nsuri": "http://emergentbiosolutions.com/20230830",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230830.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://emergentbiosolutions.com/role/CoverPageCoverPage",
     "shortName": "Cover Page Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230830.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001367644-23-000163-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001367644-23-000163-xbrl.zip
M4$L#!!0    ( -,S'E?**K;%9!4  *)I   0    83 X,S R,#(S;W1C+FAT
M;>U=:7/;1K;]_GY%/SN32:I(FJ06:W%<)<MVK'E>5)8SJ?GTJ@DTB!XUT)@&
M0(KY]7/N[0:XB)0MQY;HE.TJB<32RUW/70 ]2:O,/'V2*AD__9\G_]OMBN<V
MJC.55R)R2E8J%G6I\['X/5;EI>AVPU6GMI@Y/4XK,>P/=\3OUEWJB?3G*UT9
M];09Y\DC__W)(Y[DR<C&LZ=/8CT1.O[E@=X_3 ;J\<% [L6[N\DP.MB+]J3:
M352<[,3)Z.#_!P]P*R[W]Y35S*A?'F0Z[Z:*YC]Z/"RJXZF.J_1HT.__[<'2
M=96ZJKK2Z'%^Q*O%69V-A305IL[D6,G>OXOQ U&Z:.6 OS_,L;-77!UGTHTQ
M[<A6E<V.]C#K1+E*1]*$&7@R?SHL:*>_7URUZ[^VBS6K2VQ>@48.5_N/[4TW
MG6O)LK3$0RQQ88H(S% NS-'<$5ECW='#/O\[IC/=1&;:S([^?F%K%REQ(?-2
MG#O[]TZ)3]U2.9WX"TO]ASH:## +?YT&?F <HW/5\&<P)*:\R)0;DU0]T_;"
MFKK2-B]_?'@P'#P^%F]/WI^>O/WQX>#Q+K[(4AIQ43@Y$Z]EG4>I*L4[D%I4
MJ8+<U;0+\49>DE3J2IS;LM0CHT1BG7B!ZV8V5Z*RXI4R!58_44**USK!!<YF
M0N;B7:&MCGG,V)9*A+5%LXUT+60<8[JN40F$8;^AJ\YC;.FH.S@HJJ].U]VU
M="42#O>/FY7?_1*.EV@SV.WM[Q,Q6GZGLA0V272DI3$S4::Z*&!4=(7##5,C
MS]2.L% #G8/]A5-EY'1!8H+].)6/JW153HR](E:_.C5+0K,KH.'@OX&Y(1G)
M9%EV1.SJ\8\/=Q\?%ZETF8QFD(18C)V-(#&8PF+&CL!BI\H8^FUSVJIPJI+:
M*%=^%XXO)AP;]7VJ0?N18J%(M"NKCC#0W&XI)\1)U2BJR%0,B<J]TENOS[;1
M9SD!QR29!!*>5)D)+,A(0;)R&J5*=2DN5%&I; 0!G&I(EH1!R>M$1E7ME MV
M"5?5X[$JR0F^9S$ /31(8Q/QP^YN[_#P%H;XNY1\M@EQ*I,:TT0VRW1%W(!V
MJ[RL';%SY*R,A8PB16HNIQ+& A]9O6$Y+"XIZZ* [2%9P1D,J<G$U".C(Z')
M\H#'9 KJHFRM1MZ8EUAC%#UBCR54@D%@NF3DX';FQLM=]QV?Y:]71& DHTM:
M5QYW RL2_G=\5[+QZ\G9AU<OWE\\^^W]KQWQ)NYUQ/W)R8.G)_6X!JMV^NL6
M<>_$ZG@L#'3\P<9RUA%K08\XRZ.>^.GMORY>_/AP[^!8O'AV\3.D-<?*(\CV
M?=+W%@ZV,=5KC6TN::O P(K5,+C2N0G6^=P ]];N^-Z92>BP"_WN!G B?GKW
MX?3G8&?( &UT8O?)0" M0!61 <V(0MG">%\J1]KH:D;+AJTK+'@"%@ *!]>I
M5A'P5K&B(R!6!;MN*TH"]$:3E)%H72I5" /73U(6CI&?J'-=:7PO9:)ZXL55
M@1,T0N ?739W%< # )L<RHDQAL[OE8?$L+*20![.[QF*!L1!AU4!E<K@M<@A
MPJ/%CE<[ H"=Y;@ 6P@L+;>4DT9? K3!)LI\9GIWN\C'O<'>)\$16VJR7T=.
M&1BRB3JN;''4W>D=K GZ1[)4-,*#IX.M)#EB:'C,F9((KV11.'NE,UDI"(^:
M<.2C2((RG=>5HJ!',>(64T1 QN+.N.9@>FXK&IC=826JR--1&*X]&FK@4R3K
MDH$R%$X3Q(5JQ4H":L/PT(6_]2[^6NP??A6;\947W=G93J']0$X+JY9C%3P6
MI*G2F0_XYG$@QI\@(F.'+!U90Q+$93D?]!OQ7BMPV\ZBW>WDT"L?DGL4=%=T
M79=;_%RZ>N2VG<1=A),$U'PRI"MA?B]U17DR&%CG9B$%:KU)'5NZ.)+!\%Y'
M=QV<A*V7EY02C35A11SV&)T@%E0-Y"H]9D2HJR+*TB4-I!#35!MR#2 W)E[6
MQ (WVCQ79JZ*<V1_Z\#W3G,?_>V4@A,8,I_HXH2H30!5(>;X0OS*; 9^6*&N
M0'FM.'0DMB%8275^R1$97<=.''1.B9$IXIB28E#BT=PQSUWZF;C,[53,;$VB
M$O)@E2CJ"FLI?/(K!Z^ESX+!KL8>!F!D-KTY#5QA?"O&5#^BF;#V"J(D/)4Z
M3//!,: Y9/,YXK]GD!NMQ!O$D65'G*L\%V^:_%Z1SDK*'><\3: "Y?P2<0J2
M,6U. .*Q !#'V+'/ZYXV</X4&+\G IO/=<15@[K8'+W1DAF VV9#M/42M@/'
M<1*D<6$GG-L.0Q-U+&B>M=N#*E(^D?2S3.VT9*)*BLN<*O#[JT?Z/.*1!H-U
M] GB]F_*K 3[L97ZT!-G59N9Y3AB5+,%9/,(@W5%9JG6)4DYQ"[ETD\E4@O8
MP#>"*ZEW6\3BPD[]A:6O$3'NA5R5N)YP,/&+(LO.TA'2#S; S4&6B@R2DRM%
MRF!)%T242JAD+PC#MYL _)VRXZP0,E,<3;-^>>= <(N307 %66TXZ=,!S"=(
MAE^L-)S_N;&LT]FLC.2N;O9)'8AL9&J..=JP4IS"QM4994)H!#*1D5?KQ6I"
M1?:)*]V0@1'\&LPAE'J>T )?K]>0.FW-:"&SU1:)-N:X"-!FZTH,95MB\(,T
M5C;93!58)5]^(*=+0* BLL,Y1RF=4_^I]42:L#$(SSC%MGX8#GM[?;Z#3'U/
M_,[.O$U13JV[+'TQ!-:IRFDSI$0$"RC;@+7E2]D3RH3'(;'4\0K5K-Q_L7$=
M<5Q8JHI2%/ 5>J+C&OMHZ=7[=C7C!NAP9P@!$T) $XKP?7&D$6>UFO#"L;:B
M06Y+FJF<D;@B^ \N#_Q4B:-MD'K!RY%(M#*PDG>;JB#![-!LS369D9N'!&OD
M%E= !2 L]#/D* V01-GZS*WT.XQ3SF5MQ._:&"TS6((+E6OX@'^2P)_#J#&2
MZM!<)/2E>$9-,Z#[^N3V'8OH0O;3V[8V&1S,E^1\<-=CGI##9\,*"\G-/\M5
M-84]LJWW^61\([RDQYGT.2'@+D-WA; D%-J\D6W 3X?C]#C6[$1PCDMIM7.-
M+9I;IMA"YD*R"L/":,5>F"#\&=]74:&![0X&#=.E2AIV763E>^*=7PN&H0O/
M**/OBQ20SK81Y*3=YG,JWTPY#XL-P7B1/MA\;+D,'8J OG(<3RRH000K," 6
MC$\1L)1E_\.HU6)!U&. P"NU)@ZF56<%\"+ML!F0H83*&3IL*$ 2<#>(L5):
M[U:J"]P$(:&/0I_%]JWK(?RFAJ[@#_KS6^2HI-+:YEN^7 L4U#[3(W!P$X6&
MGT2AP3)-%G^F;MY5,E;=$83WLBL3+/K(6^P'?\$VN$VN_ANOG7/\3@ 2D"LD
MO1/NF)1C:F?P3C>D: "*2UTN5(S)1U/HZ:0N0V2_%E[!(N(@=5,9[I6CF8;]
MP7ZG"<L)&!3D;V$:$PO#Q)4RWS6A&*@NV1=.+02XQY9_$>8!QMK&2,4KBS44
M387&KM76"K]RRA?=A WNTU/^L#OH]3TZKJ:VR]Z@ =;S6*=I/QCX2G\' :@V
M<7!US .XB"[[C&M^XAI-%D V][(L6'RPRE'@L12-D.6ONI"3R\4")T46#/$1
M_4#0J(#I9%XU[2]P3"$+Q+5-2O3D['(@/[B0H R#L69$.#HWEKG^@WTCSG+B
ML2D:8[E>KJB%SGM^%IK0.D.Q5@&FI)2!W)Q@P?VMR)'H$O[,+9905@$(9!PO
ME:I=I8>@@4P4PX40KFCP%N55YJ2B+,9"#?AZLTZ'R:\CQ*P.1/;>M WD1Y1%
M:V@.1D"K%N9L,G(1S8E0*[HTG*1M4J',%!]<+:"?EN]+VD99@EP9O_Z)I'XW
M9L=_$"3I1*MXD;01I%CGOAQ7S]M6YSF1@.8*")TT353]7#M(+Z[9/1@>=WQC
MHR*HDDZ]VK4<8XE)=0&I-I>T!$S']+LI%N72X&SJTW_Y(HT_/[2[,P,=1;!M
MH:^ .@!!"-_" Y *(A+NHPV]5[#8>?>WF)#72_(H(=,A349".W@L,HH,P% R
M'$RP5I?)*B[(>[Q8__3&>CCHB3>$O"& N3C8)2M$0,6;>I),/^JUD:J@^:T4
ME34VP+:8!#0@X)@ -P>&4-X5Q?VHLI=1:JT)6A\R6^M-Q5^KF+MWG\Y(+'0^
M1G8,$BMOO1 QD&[G+0P@+]4PG]QK*W4+B1INU%JT'=0-2=+=A#.K\46*I7@_
M0[?7+ G*48?-HE%M8/[VUWC:%.92]I%KQ!-I;LZT,9C:6X$Z6:NLOGF"FBM8
MZ>$K3!?!JXDY4PH5@:4(0?%4+3%!8>J:O#,E0>/61Y46_H/R:;F:-MC0A[ A
MZ^;4<AMLS"RDZ)2TG(L.M/4FQ]U4 $/?T#? K9<08R:PSBFK'"SM!/"X"GSJ
M@0"W=RY_+IBXJ\=D3D:VKC;*XQ8M_T_WCX9^(>]R7CX_Z7J%I,R07=]ZR;>U
M%JX)@,CL<6:GK43/\_IMF:"M</9NS*J'6E\]*H%\")PNE[@7D5\/J*"@^B9&
M]04"QHVY(KLK@7[$;P2I2EA7PE\PE%O$O)MD;WW/\A8M?@.6FZ^\P^8PTUPM
M9SF;EZ Y?1D2;(3I>X+LS7#/V_#./*T]46UNG+.1L4J4C^I"6RT_3$:E]C$A
M,Y':0GE7FU.J$GZB*)0OH ^/2TN7+-5^%ZNM)+^^'0_2A-B!A7M".<VR90!)
M(D7R1EUYM^R9M"[96;; 4'(LD%A 4]*%"97\FR99PG*R4!@^"HG'*=7L)LK8
M(F0!VFH5SSX/'ILNVU!CXQ5+4](<"?8@!2+0,4,4BGH0P%6,'1 44#T\S,$*
MNCP/4;=MZ*(IPZ-:O,C0]C#2Q,@T]Z7^-L_*F0D#'N;>>4B6Y=1.:5>%D?FB
M$)!2!QD88$"/W'UI XA_V-_I-PX'@D0LW#D\GJH1#JCPC58"LAJ,7U- %0Y_
M+(61)%_O&1K.NL7 BXY=YA'C-@]F7^O\4L5G^7UBVH\^-W)/M/DP)2CE[I<T
M)$[;29ZSG#K1G<SNDT#;[SHOJ"_BE70CF)8+2KKY!]^W9M7KZ?J!RV6. D5$
MQXH\D6^F\.9W*EW<-=9RRU39[,JG,T,2(U.2L\0A*7WN](1BF@L5U<Z'B:_Q
M:^R+A>\5 7IQ$C$P&QP>[O7$"1SF?.A.2#'XV&H^(W6N::I.LAL@9['8]K%P
MH5-C&3(ZJ;KF:2AP4HX>1%XNA&+XK:RDW0)-KT+F>TU?2(\8-L@/PP6 %TI6
M4^:4*N<ZF5V[XWOA\!IEA]\+AUMI2!<L$ "D?U\*HH8XM"DV+:*0\T@7N+3M
M=PEG1LIHV*K5PTV^Z/KQVL2K!Q5BUFS-V+[Y;?4H]?I$5&]8.3ZVTJP>(Q"?
M7YL/ >_J(<+9J\?*=-UB*5"Z=FSI0BY&:/!*.FIF<K[WN23L/I%.^YRS;SNV
M"?=CDL7/U5CZAI+FQ*BN0J(4JI#Y0@N%^9PRN((+*>ER\F/L9AIKQ":+LNF+
M=NOE9I](PU+VF&NK%'XVK2Q,O)!>9S8GH8>&V1*V,7=;2<WQ%J45@Z6,Z,G@
M2HQK274]%<I45"3::&+GS^9&6 8.4K)"<MN)9P<G*B'??BR=^"2O\<VT):*Z
MPJ^+$S+80C,.D;G.J0,V%Y0@+OV!"&I,)6/R]R2"8 ^-WJ%.<-_M5]:FHN?W
M:6[_W$%[(3V73Z$T$6V1*/,U@[8=SU"26GJ&@6-BT)H9:7T3&>VAIDY,HWV"
M/+^92, >-]*P+&!!N:8VXZ*91S@Q4Z'I-%J$3HSB.R13JJCH#D=]F!3JPR08
M.>5VHMCRFIG<U W$I;PB]E7:FU;#A<C$4/1*F>&EW*@7%GXF1+NHSDJN$'!E
MF"I&7!H5><TONR 1#T6$BH&4=2'Z]\SQC^TMM VTQ<457E+J>3TC?<F*FCTC
M#OQ'LYOW5EZ33LHLZ)AQ(#V9Z]DM^2TMX9ZE%[70:KE<T>PG*+'VQ3;.C6.%
M%@L*A3W 6VU4[ OS;3%N ;62AKZXHM+*F%XYE(5D$C79JKS)W3>)]QMVMD4A
MP"U>RT3MTQ5H6?+["3:\V.(35GI"8K%I??V/K6\PQ/KH.1#9K,>_+N&.UG/-
MT_OUR*JB0*^:ZC4(]2Y7XNOZUG6$I]%[9>2&7.U=+FNXV^\^WN]W^WM[:Y^'
M#K,/(_P__.*SWV+OJPF5/SW[36F4U$M,]N/#_=UCRB12#>M6;XRY2Z4[RR>*
MHNTEO;M7J7JO88M=+%[#K<C4W*^(O_CGN7_&+ 6:$R\!CW+.*;RCMYS!:]V[
M_NWO#+H[._O];=4&X[GH_HPV5-R?U<;V#H-3EL;(HE1'S8?C6)< A[,CS9U1
M7;[I<^+0P\/>SMX!Q<855E/%S<0A;.YQV/RHBM><.^@=]C>?[O<&FV_]/NP7
M&_81\ZW-D31I"<9=%2%.4P+M_O)@I\U<A'>2'?7%@*]JIOAF+KW]EH,:48,4
MQJ'BHXX%F8?C[=SA[8FQ?,]@[]I-P^**;EM\;2J]E.Z:A;#%QCP9579U,OMT
M0'^3K=WK?30SV-_<Y3;L'=SZA36?N="#3U@F\-DIYU%]=?>Y+KGF0"C#65_>
M/7<<S6(K/?$;=YXUS=2+KS]"[+[PD.9R6'!'>[D1[555X6,G?N$H_YA.I[TH
MCGIC.^'OX?%5_@R.Z,A_;'=(KV6^<_: YIR,B,4_ZEP)W^8^!+6YFQ"'0P/\
MT/>_KX2WWQ7M2[T:Z(X5[9RZ3<*K)9Z[>CQ_(.XYO[&)WKD<EW\!I<NCU*M9
M/BG]ATGI''^@1[N[39=8E]HV207O40-?JI&K*>E%[:>L;=?5<.^['MY*#]>^
M[.KKZN%%E&IC$!6^^%='_&IG]+H22ME0;E%'XMT_>LWKR!=:%$^?G8EGUE[2
MH[@)^-YT1359Z+?-DZNO]<B1C.!X\\:4SOPL-6]P'R.GKU]QC]@WJL5Y--*]
MW&2]7*>M.H^(1/SI[;/_VWW<WQWL\;=[U-J3PFDCAH<;5?:[QMY*8]>^_.SK
M:NRO-O]#&O6'>'_>$:=UEG&+YZ_OH;6U49?2B3<7':$J(4U/G&7<J@E\ZFIZ
M^.YZLW"CNLMOL>/*P]C8$;T4)5"&:P<S?J@]EY/0-7/K%PA\$@4^_=5 3!,8
MJ0].UIF\!\T:]ON'XBUI_-[A\?[CG_9^9O-P<'C8/>P/ORO2)RK2;1]H^@**
MM.&QN=Z\E0DN(+?T.MN)5E/OBRZ@<.31?*&NM_!0WC?HN1Q3H"8"]*SS?WZ"
MNHB]TXI5(FM3\6>J1_JCM-5N?\>[M4"HOPW[[YD>^/#R[.W):_S>Z0WZ/5"E
MB)-[T,K;^K5'G'K]WLRU4'K=6:'5XD__-Y(>\=]F^B]02P,$%     @ TS,>
M5PB@)U]P#P  DV\  !    !E8G,M,C R,S X,S N:'1M[1U=<^(X\GU_A8Z]
MNTVJ8F.;3Y.$*X8P,]3.D!1D=O?NY4K8(NC&V%Y))+"__KIEFT" !+)D8+*9
MATQ 4JN[U>HOM92S?TU& ;EE0O(H/,_9II4C_ZJ?_<TP?GO7_40N(F\\8J$B
M3<&H8CZYXVI(U)"17R/QE=]2<A50-8C$R##TJ&843P6_&2KB6$XAZY4VBEJ_
M:/G4H25C4'&+1K%,+</U+&HX%G4<QCS7+A=.;FJ^95LEKVH955;RH%NA;U"K
M[QM>H>!;;MDK.2X]\6NVYUI%:M.2U2\5G0+K]VUF.<6J,W MV^T/<-JA OJ
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MIWL]^NG0()I@6>+'9D Z5(+KTXL%G9(B&:&_%@2D#RR_I3S0;@AX=G+(@EO
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M<,*X..[NB+_R8)A09CRUG)3B672;[[K[CG W_%==7;<7&-RE+6_7&6-<V\@
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M[>&/X(9E?\93R)>3-UG6WZZ>D'>*!P[?W'_0/73_7G'XYC]02P$"% ,4
M" #3,QY7RBJVQ605  "B:0  $               @ $     83 X,S R,#(S
M;W1C+FAT;5!+ 0(4 Q0    ( -,S'E<(H"=?< \  )-O   0
M  "  9(5  !E8G,M,C R,S X,S N:'1M4$L! A0#%     @ TS,>5QVJ@=MZ
M @  KP<  !               ( !,"4  &5B<RTR,#(S,#@S,"YX<V102P$"
M% ,4    " #3,QY7FTC%6Z\*  !$8@  %               @ '8)P  96)S
M+3(P,C,P.#,P7VQA8BYX;6Q02P$"% ,4    " #3,QY7^6I>AN &   N,P
M%               @ &Y,@  96)S+3(P,C,P.#,P7W!R92YX;6Q02P4&
/  4 !0 ^ 0  RSD

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
